Efficacy and safety of human placenta extract in alleviating climacteric symptoms: Prospective, randomized, double‐blind, placebo‐controlled trial

Yoo‐Kyung Lee, Hyun Hoon Chung, Soon‐Beom Kang
In: Journal of Obstetrics and Gynaecology Research · 2009 · vol. 35(6) , pp. 1096–1101 · doi:10.1111/j.1447-0756.2009.01066.x · PMID:20144174 · W2166451099
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This randomized, double-blind, placebo-controlled trial found that human placenta extract significantly reduced climacteric symptoms compared to placebo over 4 weeks with a good safety profile.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIM: To assess the efficacy and safety of human placenta extract in the relief of climacteric symptoms. METHODS: A prospective, randomized, double-blind, placebo-controlled trial was performed on 108 women with menopausal symptoms. Human placenta extract or placebo was administered to the women for 4 weeks. Climacteric symptoms were assessed with the Kupperman Index (KMI). RESULTS: Both groups showed a significant reduction in the KMI score at the end of treatment. However, the decrease in the KMI score was significantly greater in the product group than in the placebo group (-12.30 +/- 10.44 vs -7.15 +/- 9.11, P = 0.012) after 4 weeks of treatment. The level of lipid profiles and liver function tests demonstrated no significant changes before and after treatment in both groups. CONCLUSION: Human placenta extract reduced climacteric symptoms more than the placebo. The safety evaluation showed a good safety and tolerability profile in the placenta extract group. The results of the present study suggest that human placenta extract can be an alternative therapy in women with menopausal symptoms.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (14)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T06:45:02.717393+00:00
License: CC0 · commercial use OK